trolamine salicylate has been researched along with HTLV-II Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fridey, J; Garratty, G; Hutching, ST; Murphy, EL; Nass, CC; Newman, B; Ownby, HE; Sacher, RA; Schreiber, GB; Smith, JW; Wang, B | 1 |
| Ameti, DI; Fridey, J; Gibble, JW; Glynn, SA; Murphy, EL; Nass, CC; Nemo, GJ; Newman, B; Sacher, RA; Schreiber, GB; Smith, JW; Wright, DJ | 1 |
2 other study(ies) available for trolamine salicylate and HTLV-II Infections
| Article | Year |
|---|---|
Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection.
Topics: Adult; Arthritis; Asthma; Blood Donors; Female; HIV Seronegativity; HTLV-I Infections; HTLV-II Infections; Humans; Incidence; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections; Survival Analysis; United States; Urinary Tract Infections | 2004 |
Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.
Topics: Adolescent; Adult; Aged; Arthritis; Blood Donors; Cohort Studies; Female; HTLV-I Infections; HTLV-II Infections; Humans; Infections; Leukemia-Lymphoma, Adult T-Cell; Logistic Models; Lymphatic Diseases; Male; Middle Aged; Mycoses; Odds Ratio; Pneumonia; Prevalence; Tuberculosis; Urologic Diseases | 1997 |